Skip to main content

Table 3 Results of patient questionnaires (n = 114)

From: Implementation of genotype-guided dosing of warfarin with point-of-care genetic testing in three UK clinics: a matched cohort study

 

Very acceptable (%)

Acceptable (%)

Uncertain (%)

Unacceptable (%)

Very unacceptable (%)

Q1: How do you feel about the information you have received regarding this pilot project?

71

28

1

0

0

Q2: How do you feel about the opportunity given to you to ask any questions about the test and/or dosing method?

77

22

1

0

0

Q3: How did you feel about giving a mouth swab sample?

72

28

0

0

0

Q4: How did you feel about waiting to receive your warfarin doses?

51

43

5

1

0

Q5: How did you feel about coming back to clinic in a short space of time?

46

46

4

4

0

Q6: How would you rate your overall experience?

60

35

4

1

0